Occurrence of Parkinson's syndrome in type I Gaucher disease.
about
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseGaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathiesImiglucerase in the treatment of Gaucher disease: a history and perspectiveMulticenter analysis of glucocerebrosidase mutations in Parkinson's disease.Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseThe genetics and neuropathology of Parkinson's diseaseGaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolismMitochondrial dysfunction associated with glucocerebrosidase deficiencyLoss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cellsGenetic susceptibility in Parkinson's diseaseGlucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseAdult Gaucher disease in southern Tunisia: report of three casesCost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease.Gaucher disease plus.The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryMultiple pathogenic proteins implicated in neuronopathic Gaucher disease miceComparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.Greater risk of parkinsonism associated with non-N370S GBA1 mutationsThe risk of Parkinson's disease in type 1 Gaucher disease.Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes.Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.Gaucher disease: insights from a rare Mendelian disorder.The link between the GBA gene and parkinsonismDevelopment of targeted therapies for Parkinson's disease and related synucleinopathiesThe underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patientsModelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.The genetic background of Parkinson's disease: current progress and future prospects.Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutationGaucher disease and the synucleinopathiesCerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseSignificant study of population stratification, sensitivity analysis and trim and fill analyses on GBA mutation and Parkinson's disease.Parkinsonism associated with glucocerebrosidase mutation.Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseasesExploring the link between glucocerebrosidase mutations and parkinsonismSustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsAstrocytes and lysosomal storage diseases.Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease.Premotor biomarkers for Parkinson's disease - a promising direction of research.Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling
P2860
Q22242985-0877F32C-AFD4-4043-82A2-E205970D9E11Q24307627-77E70739-FB2B-463B-B8E6-1E3C097B3F87Q24631426-4133C515-D909-45CA-A19D-465C6231CC26Q24634577-569B643A-1549-4E93-82C7-C53BC0103BCDQ24656668-20FBB373-53C7-4F6F-842B-2E5B1655D31AQ26859945-0351AFF7-894F-49B5-8797-B0E662230FFCQ27013427-FCAE0B7E-EF6A-441D-80D6-099AAA7E67E0Q28115678-EDB17C45-47D7-4488-A4E3-AB56F8731C39Q28118642-74427170-6210-49CA-8BCF-10E56A0E1F79Q30435626-75A91222-B052-4316-AA09-672A9E5C8823Q30483458-8DDD7B3E-20DA-45B6-9FFC-B150AC8B3628Q33399105-C2FB3896-D596-45C1-B88B-B0AE5F104D42Q33615777-CA6448D0-13EE-4D28-A544-70A74AD90BD8Q33679677-3FD16F46-1528-4A14-A986-BA82A80E4093Q33743729-96BE257D-7409-455E-AC34-9B8B02E55FCEQ33847578-761866F2-3345-4B80-8085-F704DE7E0E85Q33849233-86D376AD-5C2E-4AF6-B4CA-ABEC6D935886Q33916685-B36A5B46-B616-4F7B-9519-0B271311ABD0Q33919614-C01BC3A5-03BF-401C-9A27-2E172ED5AB15Q33991709-582BC6DD-04F8-486E-A212-4252A5CEC958Q34037141-ED2D2E61-0CA7-49AC-B14D-9BF9C5AC8AE0Q34077331-5EBC25C0-060B-43F5-8216-84E8FEA69DD5Q34077492-83A67A04-F16D-4878-BA28-F845C0584639Q34238616-041430EB-4C09-49BE-B990-36929994CE81Q34432912-1C7E0753-BD98-4515-A5CF-403DAB33C227Q34485240-660D6D06-BD87-4898-8B88-081B24D28E51Q34513714-838700F2-63D2-4D06-879F-960496EDF775Q34555995-17667715-4A95-4006-9E56-C41F5AEE846FQ34795306-09882B56-3074-4F04-9430-E2E23925DAF3Q34806122-16873C13-14D0-4B5C-83EA-42C6FC17978EQ35045322-66F3E6D0-4BA5-430E-8A3A-3E55CC8A7165Q35091693-2280B31E-4C4B-4B50-8930-18A3A767F153Q35150090-77531C7C-317C-477C-8139-A8AB17914B8FQ35955350-1B86BE56-04A6-4F28-B4ED-36102455349FQ35982198-A3779352-1BB2-48A7-BF7C-31ACECB42D19Q36041420-C6983BCD-0DEB-4578-A467-1940D0CD9C62Q36332588-76E4F8D4-3882-4F18-A3BD-5A0371351561Q36389683-EBEA07B9-C7D7-4437-88E4-D3A6028A281AQ36444517-34305620-8DFD-438E-B01F-1B5B776175E8Q36460324-24313EC0-B068-40E1-A353-27074EF0C3CC
P2860
Occurrence of Parkinson's syndrome in type I Gaucher disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Occurrence of Parkinson's syndrome in type I Gaucher disease.
@en
type
label
Occurrence of Parkinson's syndrome in type I Gaucher disease.
@en
altLabel
Occurrence of Parkinson's syndrome in type 1 Gaucher disease
@en
prefLabel
Occurrence of Parkinson's syndrome in type I Gaucher disease.
@en
P2093
P356
P1476
Occurrence of Parkinson's syndrome in type I Gaucher disease.
@en
P2093
Abrahamov A
Neudorfer O
Turezkite T
P304
P356
10.1093/QJMED/89.9.691
P407
P577
1996-09-01T00:00:00Z